"In vitro" activity of pentamidine alone and in combination against clinical isolates of  carbapenemase-producing and colistin-resistant Enterobacteriaceae by Ramirez, Cristina et al.
Biosaia (revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria de la UPO) nº7 (march de 2018) 
http://www.bioinfocabd.upo.es/biosaia/  @Biosaia 1 
Poster 
"In vitro" activity of pentamidine alone and in 
combination against clinical isolates of  
carbapenemase-producing and colistin-resistant Enterobacteriaceae. 
Cristina Ramirez, Tania Cebrero, Gema Labrador, Jerónimo Pachón, Mª Eugenia Pachón 
Ibáñez. 
Clinical Unit of Infectious Diseases, Microbiology, and Preventive Medicine Infectious Diseases Research Group/Institute of 
Biomedicine of Seville (IBiS)University of Seville/CSIC/University Hospital Virgen del Rocío/Seville, Spain. 
Keywords: Pentamidine; Carbapenem-resistant enterobacteriae. 
 
 
ABSTRACT 
Motivation:  The increase in antimicrobial resistance rates and the difficulty to treat patients with infections caused by these 
kind of pathogens may urgent the search of alternative treatments. The objective of this project was to study the in vitro activity 
of pentamidine (PEN) alone and in combination against these kinds of pathogens.   
Methods: Fifteen different clinical isolates: 9 Enterobacter spp., 5 Klebsiella pneumoniae and 1 Escherichia coli. MICs were 
determined by microdilution in Mueller-Hinton broth at 24 and 48 hours. The assignment of clinical categories was made by the 
EUCAST criteria. MBCs were measured following the standard protocols. Bactericidal and synergistic activity of PEN alone 
and in combination was measured by time-kill curves at concentrations of 1xMIC in different time point. The in vitro prevention 
of the development of resistance was analyzed in time–kill studies. 
Results: PEN MIC range was from 200-800 mg/L. All Enterobacter strains were susceptible to doripenem (DOR), 
meropenem, amikacin (AMK) and rifampicin (RIF); also were susceptible to gentamicin (GEN) and tobramycin (TOB), except 
E. cloacae 32 and 297. All Enterobacter spp. were resistant to colistin (COL). Fifty percent of the strains were resistant to 
tigecycline (TIG). K. pneumoniae OXA-48/CTX-M-15 was resistant only to fosfomycin (FOS). K. pneumoniae KPC-3 was 
susceptible only to GEN. E. coli NDM-1 and K. pneumoniae NDM-1 were susceptible to COL and TIG. K. pneumoniae VIM-1 
was resistant to GEN and TOB and K. pneumoniae VIM-1/DHA-1 was resistant to TOB, DOR and COL. All strains were 
resistant to FOS except E. cloacae 190.  
PEN alone and in combination with GEN, AMK, TIG, TOB, RIF and DOR showed bactericidal activity after four hours against 
K. pneumoniae NDM-1, K. pneumoniae NDM-1/DHA-1 and K. pneumoniae OXA-48/CTX-M-15. PEN together with the tested 
antimicrobials but TIG showed bactericidal and synergistic activity at 24 hours against E. cloacae 32. In addition, PEN 
prevented the appearance of mutants resistant to aminoglycosides and TIG in the carbapenemase-producing strains, and 
TOB-resistant mutants in the E. cloacae 32 strain. 
Conclusions: The association of pentamidine with the antimicrobials studied confirms a good in vitro activity of these 
combinations against carbapenemase-producing and colistin-resistant Enterobacteriaceae, suggesting that they could be a 
new alternative for the treatment of infections caused by these kinds of pathogens. 
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